Cargando…
Oncolytic Bluetongue Viruses: Promise, Progress, and Perspectives
Humans are sero-negative toward bluetongue viruses (BTVs) since BTVs do not infect normal human cells. Infection and selective degradation of several human cancer cell lines but not normal ones by five US BTV serotypes have been investigated. We determined the susceptibilities of many normal and hum...
Autor principal: | Li, Joseph K.-K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128942/ https://www.ncbi.nlm.nih.gov/pubmed/21747785 http://dx.doi.org/10.3389/fmicb.2011.00046 |
Ejemplares similares
-
Inhibition of the IFN Response by Bluetongue Virus: The Story So Far
por: Rojas, José Manuel, et al.
Publicado: (2021) -
Codon Usage Bias Analysis of Bluetongue Virus Causing Livestock Infection
por: Yao, Xiaoting, et al.
Publicado: (2020) -
Entry of Bluetongue Virus Capsid Requires the Late Endosome-specific Lipid Lysobisphosphatidic Acid
por: Patel, Avnish, et al.
Publicado: (2016) -
Bluetongue Viruses Act as Novel Oncolytic Viruses to Effectively Inhibit Human Renal Cancer Cell Growth In Vitro and In Vivo
por: Wang, Haozhou, et al.
Publicado: (2021) -
Diagnosing bluetongue virus in domestic ruminants: current perspectives
por: Rojas, José M, et al.
Publicado: (2019)